Company / Total Assets
Tyra Biosciences, Inc. Total Assets History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$363.6M
FY2024
5-year range
$16.0M / $363.6M
FY2020-FY2024
Trend
+61.0%
vs FY2023
Sector context
#167 of 214
Health Care
What the data says
Tyra Biosciences, Inc.'s total assets of $364M is lower than 78% of companies in the Health Care sector (FY2024). Total Assets returned to growth in FY2024 after 2 years of decline, reaching $364M.
Based on SEC 10-K filings.
$364M in FY2024 with a 3-year CAGR of +5.8%.
Improved from $266M to $364M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +5.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 214This company $363.6M Sector average $7.5B
▼
-95.1% below sector average
Key checks
Key Insights
- 3-year CAGR of +5.8%, indicating consistent growth.
- In FY2024, total assets increased 61.0% year-over-year.
- Ranks #167 out of 214 companies in the Health Care sector.
- Lowest total assets in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 6.83 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $363.6M | +61.0% |
| FY2023 | $225.9M | -15.1% |
| FY2022 | $266.2M | -13.2% |
| FY2021 | $306.7M | +1815.6% |
| FY2020 | $16.0M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026